Letter on 'sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney'.

M aunganidze et al. [1] are to be commended for a thorough and accurate investigation of the diagnostic performance of several ECG criteria of left ventricular hypertrophy in a large community sample of black African ancestry. In their study, the accuracy of all examined criteria was poorer in obese than in nonobese individuals, as shown by a lower area under the receiver operating characteristics curve, and a weaker correlation with echocardiographic left ventricular mass index. The main conclusion of this article [1], and of the fine accompanying editorial comment by Cuspidi et al. [2], is that no current left ventricular hypertrophy criterion is recommended for use in obesity. Although it is generally agreed that obesity reduces ECG sensitivity because of the attenuation of QRS voltages, we believe that ethnicity and the choice of diagnostic criterion may have an impact on the ability of ECG to detect left ventricular hypertrophy in obesity. Sokolow-Lyon voltage [3,4] and the Framingham criterion [5] have a poorer diagnostic performance in obese individuals. In contrast, the Cornell voltage criterion [3,4] and the voltage-independent Romhilt-Estes point score [4] may not be influenced by the effect of obesity in predominantly white populations. Similarly, in an ethnically diverse Brazilian population [6], Cornell voltage and voltage-duration criteria and the multifactorial Perugia criterion [7] did not show differences in diagnostic performance between obese and nonobese individuals. In a group of 95 white individuals with morbid obesity prior to scheduled bariatric surgery [8], the best diagnostic performance was obtained with the Romhilt-Estes point score, with an area under the receiver operating characteristics curve of 0.662. We suggest that the conclusions of a ‘mission impossible’ [1,2] for an accurate ECG detection of left ventricular hypertrophy in obese individuals might not necessarily be extended from black people of African ancestry to other ethnicities, and multifactorial criteria based on a composition of voltage and nonvoltage criteria including left ventricular strain, left atrial enlargement and the duration of intrinsicoid deflection, such as the RomhiltEstes point score and the Perugia criterion, may still have a place for detecting left ventricular hypertrophy in obese individuals.

[1]  J. Małyszko,et al.  Circulating Levels of Renalase, Norepinephrine, and Dopamine in Dialysis Patients , 2013, Renal failure.

[2]  B. Sampaio-Maia,et al.  Sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney , 2013, Journal of hypertension.

[3]  G. Grassi,et al.  Detection of left ventricular hypertrophy in obesity: mission impossible? , 2013, Journal of hypertension.

[4]  G. Norton,et al.  Obesity markedly attenuates the validity and performance of all electrocardiographic criteria for left ventricular hypertrophy detection in a group of black African ancestry , 2013, Journal of hypertension.

[5]  J. Małyszko,et al.  Vascular adhesion protein-1 and renalase in regard to diabetes in hemodialysis patients , 2012, Archives of medical science : AMS.

[6]  A. Kopylov,et al.  Mass spectrometry detection of monomeric renalase in human urine , 2012, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry.

[7]  M. Banach,et al.  Renalase, Hypertension, and Kidney — The Discussion Continues , 2012, Angiology.

[8]  G. Desir,et al.  Renalase Lowers Ambulatory Blood Pressure by Metabolizing Circulating Adrenaline , 2012, Journal of the American Heart Association.

[9]  J. Małyszko,et al.  Renalase in Peritoneal Dialysis Patients Is Not Related to Blood Pressure, but to Dialysis Vintage , 2012, Peritoneal Dialysis International.

[10]  J. Małyszko,et al.  Renalase, a Novel Enzyme Involved in Blood Pressure Regulation, Is Related to Kidney Function but Not to Blood Pressure in Hemodialysis Patients , 2012, Kidney and Blood Pressure Research.

[11]  M. Banach,et al.  Hypertension and kidney disease: is renalase a new player or an innocent bystander? , 2012, Journal of hypertension.

[12]  J. Małyszko,et al.  Serum renalase depends on kidney function but not on blood pressure in heart transplant recipients. , 2011, Transplantation proceedings.

[13]  J. Małyszko,et al.  Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. , 2011, Transplantation proceedings.

[14]  M. Bolognesi,et al.  FAD-binding site and NADP reactivity in human renalase: a new enzyme involved in blood pressure regulation. , 2011, Journal of molecular biology.

[15]  P. Pruszczyk,et al.  Electrocardiographic Criteria of Left Ventricular Hypertrophy in Patients with Morbid Obesity , 2011, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[16]  G. Lambert,et al.  Does renalase degrade catecholamines? , 2011, Kidney international.

[17]  G. Desir,et al.  A Functional Polymorphism in Renalase (Glu37Asp) Is Associated with Cardiac Hypertrophy, Dysfunction, and Ischemia: Data from the Heart and Soul Study , 2010, PloS one.

[18]  A. P. Riera,et al.  Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients. , 2008, Journal of electrocardiology.

[19]  G. Desir,et al.  Catecholamines Regulate the Activity, Secretion, and Synthesis of Renalase , 2008, Circulation.

[20]  G. Desir Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease , 2008, Current opinion in nephrology and hypertension.

[21]  K. Tipton,et al.  Renalase, a catecholamine-metabolising enzyme? , 2007, Journal of Neural Transmission.

[22]  Xiaoqiang Yao,et al.  Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. , 2005, The Journal of clinical investigation.

[23]  C. Zoccali,et al.  Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease , 2002, Circulation.

[24]  J. Ménard,et al.  Influence of obesity on the diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy. , 1996, The American journal of cardiology.

[25]  G. Schillaci,et al.  Improved electrocardiographic diagnosis of left ventricular hypertrophy. , 1994, The American journal of cardiology.

[26]  J. C. Christiansen,et al.  Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. , 1990, Circulation.

[27]  P. Kligfield,et al.  Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity. , 1996, Journal of the American College of Cardiology.